Zuwen Sun
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2015First federal award
$10.2MFederal grants as PI13 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
13 awards · $10.2M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Jul 19, 2023 | NIH | SBIR Phase II Rapid and robust assay for measurement of in vivo activity of chromatin-interacting proteins | $1.0M | Epicypher, Inc. |
| Jun 1, 2023 | NIH | SBIR Phase II Novel recombinant sensors to study histone ubiquitin signaling | $1.3M | Epicypher, Inc. |
| Sep 15, 2022 | NIH | SBIR Phase I A novel platform for quantification of acute neuronal transcriptional responses | $327K | Epicypher, Inc. |
| Feb 3, 2020 | NIH | SBIR Phase II Multiplex nucleosome-based profiling for the development of next-generation chromatin labeling reagents | $1.8M | Epicypher, Inc. |
| Aug 5, 2019 | NIH | SBIR Phase II Novel enzyme inhibitor screening platform using modified designer nucleosomes | $2.0M | Epicypher, Inc. |
| Sep 1, 2018 | NIH | SBIR Phase I Asymmetric modification of nucleosomes for targeted drug discovery | $285K | Epicypher, Inc. |
| Mar 1, 2018 | NIH | SBIR Phase II Accelerated discovery of methylation targeted therapeutic development | $2.1M | Epicypher, Inc. |
| Sep 20, 2016 | NIH | STTR Phase I A novel protein engineering tool for rapid manufacturing of designer nucleosomes | $225K | Epicypher, Inc. |
| Sep 16, 2016 | NIH | SBIR Phase I Accelerated discovery of methylation targeted therapeutic development | $224K | Epicypher, Inc. |
| Sep 1, 2016 | NIH | SBIR Phase I Histone phosphorylation-dependent screening platform for identification of inhibitors to treat neuroblastoma | $224K | Epicypher, Inc. |
| Mar 1, 2016 | NIH | SBIR Phase I High-throughput methyltransferase assays using recombinant nucleosome substrates | $225K | Epicypher, Inc. |
| Aug 5, 2015 | NIH | SBIR Phase I Barcoded nucleosomes for analyzing combinatorial epigenetic regulators | $246K | Epicypher, Inc. |
| May 7, 2015 | NIH | SBIR Phase I Developing Novel Arginine Biased Arrays for Epigenetic Research | $225K | Epicypher, Inc. |
Peer ranks
Federal funding#59
Awards as PI#72
Patents#273
Companies
- Epicypher, Inc.Linked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.